Back to search
FDAFDA · Food and drugs·Recall number Z-0205-2027

Techno-Path Multichem AE Unassayed Level 1 REF:AE621X

Published October 28, 2026 · Recall initiated: August 14, 2026

Summary

FDA records medical device Class II recall Z-0205-2027, published October 28, 2026 and initiated August 14, 2026. Recalling firm: TECHNO-PATH MANUFACTURING LTD.; Status: Ongoing; Reported quantity: 832 units; Lot: UDI: (01)05391523442800/Lot # 65705261. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue is limited to the Ammonia analyte only. The impacted device may cause delay of issuing results to the physician. Delayed recognition and diagnosis of elevated levels may impact in timely treatment of life-threatening levels described within medical toxicity intervention decision points.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TECHNO-PATH MANUFACTURING LTD.
Distributor
US Nationwide distribution in the state of Massachusetts.
Lot
UDI: (01)05391523442800/Lot # 65705261
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Techno-Path Multichem AE Unassayed Level 1 REF:AE621X recalled?

Yes. FDA published recall Z-0205-2027 on October 28, 2026. Reported hazard: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue is limited to the Ammonia analyte only. The impacted device may cause delay of issuing results to the physician. Delayed recognition and diagnosis of elevated levels may impact in timely treatment of life-threatening levels described within medical toxicity intervention decision points.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail